Viewing Study NCT01846832

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2026-02-20 @ 8:08 PM
Study NCT ID: NCT01846832
Status: COMPLETED
Last Update Posted: 2016-09-21
First Post: 2013-05-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
Sponsor: Janssen-Cilag International NV
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C, Chronic View
None Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatitis C, Chronic View
None Infection View
None Triple therapy View
None TMC435 View
None simeprevir View
None Pegylated interferon alfa-2a (PegIFNα-2a) View
None ribavirin (RBV) View
None PEGASYS View
None COPEGUS View